PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Hepatitis B and C diagnostics: An overview • Hepatitis B disease overview • Hepatitis C disease overview PART 05: Reimbursement scenario: An overview PART 06: Market landscape • Market overview • Global hepatitis B and C diagnostics market overview • Five forces analysis PART 07: Market segmentation by procedure • Immunodiagnostics • Immunofluorescence • Instruments • Reagents • Global hepatitis B and C immunodiagnostics market overview • NAT • Global hepatitis B and C NAT market overview PART 08: Market segmentation by disease • Hepatitis B • Global hepatitis B diagnostics market overview • Hepatitis C • Global hepatitis C diagnostics market overview PART 09: Geographical segmentation • Hepatitis B and C diagnostics market in Americas • Hepatitis B and C diagnostics market in EMEA • Hepatitis B and C diagnostics market in APAC PART 10: Market drivers • Growing demand for molecular diagnostics in the diagnosis of HBV and HCV • Strategies of healthcare organizations toward simplifying the diagnostic process • Rising demand for POC diagnostics • Increase in demand for automation and system integration PART 11: Impact of drivers PART 12: Market challenges • Presence of high undiagnosed individuals • Limited detection capability and complexity of assays • Regulatory and reimbursement hurdles limit the adoption rate • Limitations of closed systems PART 13: Impact of drivers and challenges PART 14: Market trends • Advent of immunosensors in the HBV and HCV diagnostic tests • Paradigm shift toward the use of hepatitis C core antigen test • High demand for biomarker-based tests PART 15: Vendor landscape • Competitive scenario • Key news PART 16: Key vendor analysis • Abbott Diagnostics • Roche Diagnostics • Siemens Healthcare • QIAGEN • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Possible outcomes of HBV infection Exhibit 03: Concentration of HBV in several body fluids Exhibit 04: Pathway of hepatitis B progression Exhibit 05: Disease progression of hepatitis B Exhibit 06: Significance of serological markers Exhibit 07: Types of hepatitis B diagnostic tests Exhibit 08: Diagnostic strategies for HBV Exhibit 09: Interpretation of serological markers Exhibit 10: Endemicity pattern of hepatitis B across different regions Exhibit 11: Medical cost for chronic viral hepatitis Exhibit 12: Progression of hepatitis C Exhibit 13: Risk factors for hepatitis transmission Exhibit 14: Screening tests for hepatitis C infection Exhibit 15: Medical cost for hepatitis C and related infections Exhibit 16: Reimbursement perspectives of healthcare entities Exhibit 17: Global hepatitis B and C diagnostics market analysis: Developed and emerging markets Exhibit 18: Snapshot of global hepatitis B and C diagnostics market Exhibit 19: Global hepatitis B and C diagnostics market 2025-2020 ($ billions) Exhibit 20: Opportunity analysis of hepatitis B and C diagnostics market Exhibit 21: Five forces analysis Exhibit 22: Global hepatitis B and C diagnostics market by procedure 2015-2020 Exhibit 23: Global hepatitis B and C diagnostics market by procedure 2015 ($ billions) Exhibit 24: Global hepatitis B and C diagnostics market by procedure: Lifecycle analysis 2015 Exhibit 25: Global hepatitis B and C immunodiagnostics market 2025-2020 ($ billions) Exhibit 26: Opportunity analysis of immunodiagnostics Exhibit 27: Global hepatitis B and C immunodiagnostics market segmentation by product type 2015 Exhibit 28: Global hepatitis B and C NAT market 2025-2020 ($ millions) Exhibit 29: Global hepatitis B and C NAT market segmentation by product type 2015 Exhibit 30: Opportunity analysis of global hepatitis B and C NAT market Exhibit 31: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 ($ millions) Exhibit 32: Global hepatitis B and C diagnostics market segmentation by procedure 2025-2020 (%) Exhibit 33: Global hepatitis B and C diagnostics market segmentation: Impact analysis 2015-2020 Exhibit 34: Global hepatitis B and C diagnostics market by disease type 2015-2020 Exhibit 35: Global hepatitis B and C diagnostics market by disease type 2015 Exhibit 36: Global hepatitis B and C diagnostics market by disease type: Lifecycle analysis 2015 Exhibit 37: Acute hepatitis B infection by demography 2015 Exhibit 38: Chronic hepatitis B infection by demography 2015 Exhibit 39: Procurement of hepatitis B diagnostic kits by WHO 2015 Exhibit 40: Global hepatitis B diagnostics market 2015-2020 ($ millions) Exhibit 41: Opportunity analysis of global hepatitis B diagnostics market Exhibit 42: Prevalence rates of hepatitis C across different regions 2015 Exhibit 43: Treatment cost of hepatitis C-related infections Exhibit 44: Procurement of hepatitis C diagnostic kits by WHO 2015 Exhibit 45: Opportunity analysis of hepatitis C Exhibit 46: Global hepatitis C diagnostics market 2015-2020 ($ billions) Exhibit 47: Global hepatitis B and C diagnostics market by disease type 2015-2020 ($ millions) Exhibit 48: Global hepatitis B and C diagnostics market by disease type 2015-2020 (%) Exhibit 49: Global hepatitis B and C diagnostics segmentation by disease type Exhibit 51: Geographical hepatitis B and C diagnostics market 2015 Exhibit 52: Global hepatitis B and C diagnostics: Regional market lifecycle analysis Exhibit 53: Global hepatitis B and C diagnostics market by geography 2015-2020 Exhibit 54: Global hepatitis and C diagnostics market segmentation by geography 2015 Exhibit 55: Global hepatitis B and C diagnostics market by geography lifecycle analysis 2015 Exhibit 56: Hepatitis B and C diagnostics in Americas 2015 Exhibit 57: Prevalence data of hepatitis C in North America Exhibit 58: Prevalence data of hepatitis C in Latin America Exhibit 59: Hepatitis B and C diagnostics market in Americas 2015-2020 ($ billions) Exhibit 60: Prevalence data of hepatitis C in Europe Exhibit 61: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions) Exhibit 62: Prevalence rate of hepatitis B in APAC Exhibit 63: Prevalence data of hepatitis C in APAC Exhibit 64: Hepatitis B and C diagnostics market in EMEA 2015-2020 ($ billions) Exhibit 65: Global hepatitis B and C diagnostics market by geography 2025-2020 ($ millions) Exhibit 66: Global hepatitis B and C diagnostics market by geography 2025-2020 (%) Exhibit 67: Global hepatitis B and C diagnostics market by geography Exhibit 68: Strategies of healthcare organizations Exhibit 69: Advantages of POC diagnostics Exhibit 70: Recent and expected product launches of HCV POC diagnostic tests Exhibit 71: Impact of drivers Exhibit 72: Prevalence and diagnosis of HCV infections across developing countries 2015 (millions) Exhibit 73: Key factors affecting the adoption rates Exhibit 74: Force field analysis of global hepatitis b and C diagnostics market Exhibit 75: Impact of drivers and challenges Exhibit 76: Key advantages driving the adoption of HCV core antigen test Exhibit 77: Impact of trends on global hepatitis B and C diagnostics market 2015-2020 Exhibit 78: Key leading vendors ranking for instruments 2015 Exhibit 79: Presence of vendors in the global hepatitis B and C diagnostics market Exhibit 80: Abbott Laboratories: Key business offerings Exhibit 81: Abbott Diagnostics: Metric analysis Exhibit 82: Hoffmann-La Roche: Business segmentation by revenue 2015 Exhibit 83: Roche Diagnostics: Products and description Exhibit 84: Roche Diagnostics: Business segmentation by revenue 2015 Exhibit 85: Roche Diagnostics: Metric analysis Exhibit 86: Siemens Healthcare: Various tests available in multiple diseases Exhibit 87: Siemens Healthcare: Metric analysis Exhibit 88: QIAGEN: Metric analysis

Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare, QIAGEN, Affymetrix, Allele Biotechnology, Axis-Shield, Becton Dickinson, bioMérieux, Cepheid¸ Chembio Diagnostics, DiaMetra, DiaSorin, Enzo Life Sciences, Hologic, ImmunoDX, MedMira, OraSure Technologies, Quest Diagnostics, Quidel, Randox Laboratories, Vela Diagnostics, Vital Diagnostics, ZEUS Scientific.